Intuitive Surgical (ISRG) Depreciation & Amortization (CF) (2021 - 2026)
Intuitive Surgical (ISRG) posted Depreciation & Amortization (CF) of $192.3 million for Q2 2026, up 7.49% on a QoQ basis from $178.9 million in Q1 2026, and up 26.43% year-over-year from $152.1 million in Q2 2025.
Analysis
Intuitive Surgical (ISRG) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
Intuitive Surgical has reported Depreciation & Amortization (CF) for 6 years, with the latest figure at $192.3 million in Q2 2026.
- On a quarterly basis, Depreciation & Amortization (CF) rose 26.43% year-over-year to $192.3 million in Q2 2026; TTM through Jun 2026 was $696.3 million, a 32.91% increase from a year earlier, with the FY2025 full-year figure at $614.7 million, up 38.04% from the prior year.
- Depreciation & Amortization (CF) was $192.3 million for Q2 2026 at Intuitive Surgical, up from $178.9 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $192.3 million in Q2 2026, with the low at $77.7 million in Q1 2022.
- Average Depreciation & Amortization (CF) over 5 years is $120.6 million, with a median of $109.8 million recorded in 2024.
- The sharpest annual moves came in 2024 and 2025: Depreciation & Amortization (CF) climbed 2.96% in 2024, then surged 42.42% in 2025.
- Over 5 years, Depreciation & Amortization (CF) stood at $98.6 million in 2022, then climbed by 19.78% to $118.1 million in 2023, then gained by 2.96% to $121.6 million in 2024, then soared by 38.49% to $168.4 million in 2025, then grew by 14.19% to $192.3 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $192.3 million (Q2 2026), $178.9 million (Q1 2026), and $168.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 192.30 Mn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 729.00 Mn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 355.00 Mn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 42.70 Mn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | - |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | 68.20 Mn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Zimmer Biomet Holdings | 18.00 Bn | 17.59 Bn | 1.54 Bn | 270.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 192.30 Mn |
| Mar 31, 2026 | 178.90 Mn |
| Dec 31, 2025 | 168.40 Mn |
| Sep 30, 2025 | 156.70 Mn |
| Jun 30, 2025 | 152.10 Mn |
| Mar 31, 2025 | 137.50 Mn |
| Dec 31, 2024 | 121.60 Mn |
| Sep 30, 2024 | 112.70 Mn |
| Jun 30, 2024 | 106.80 Mn |
| Mar 31, 2024 | 104.20 Mn |
| Dec 31, 2023 | 118.10 Mn |
| Sep 30, 2023 | 103.50 Mn |
| Jun 30, 2023 | 92.30 Mn |
| Mar 31, 2023 | 87.70 Mn |
| Dec 31, 2022 | 98.60 Mn |
| Sep 30, 2022 | 81.90 Mn |
| Jun 30, 2022 | 79.80 Mn |
| Mar 31, 2022 | 77.70 Mn |
| Dec 31, 2021 | 74.30 Mn |
| Sep 30, 2021 | 75.70 Mn |